MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $103,000 | -59.8% | 83,100 | 0.0% | 0.00% | – |
| Q1 2017 | $256,000 | -27.7% | 83,100 | -4.2% | 0.00% | -100.0% |
| Q4 2016 | $354,000 | -35.8% | 86,700 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $551,000 | +10.2% | 86,700 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $500,000 | -37.5% | 92,700 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $800,000 | -0.2% | 95,600 | -5.8% | 0.00% | 0.0% |
| Q4 2015 | $802,000 | -7.2% | 101,500 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $864,000 | -31.2% | 101,500 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $1,255,000 | +24.1% | 101,500 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $1,011,000 | 0.0% | 101,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,011,000 | +6640.0% | 101,500 | +2502.6% | 0.00% | – |
| Q3 2013 | $15,000 | +275.0% | 3,900 | +550.0% | 0.00% | – |
| Q2 2013 | $4,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |